We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
-5.2%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$3.55B
AUM Growth
-$395M
Cap. Flow
+$563M
Cap. Flow %
15.85%
Top 10 Hldgs %
43.38%
Holding
114
New
26
Increased
23
Reduced
23
Closed
40

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$187M
2
PFE icon
Pfizer
PFE
+$168M
3
GILD icon
Gilead Sciences
GILD
+$125M
4
UNH icon
UnitedHealth
UNH
+$125M
5
LLY icon
Eli Lilly
LLY
+$93.4M

Top Sells

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$84.3M
2
AAPL icon
Apple
AAPL
+$80.7M
3
BRCM
BROADCOM CORP CL-A
BRCM
+$75.5M
4
LBTYK icon
Liberty Global Class C
LBTYK
+$74M
5
VMW
VMware, Inc
VMW
+$72.2M

Sector Composition

Rank Sector Weight
1 Healthcare 59.47%
2 Communication Services 6.34%
3 Financials 5.66%
4 Technology 4.95%
5 Consumer Discretionary 4.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CLVS
1
DELISTED
Clovis Oncology, Inc.
CLVS
$235M 6.6%
2,552,887
-160,774
-6% -$13.9M
HCA icon
2
HCA Healthcare
HCA
$82.8B
$183M 5.15%
2,367,026
+321,743
+16% +$28.5M
WBA
3
DELISTED
Walgreens Boots Alliance
WBA
$179M 5.05%
2,159,167
+587,146
+37% +$53.1M
UNH icon
4
UnitedHealth
UNH
$396B
$170M 4.78%
1,465,502
+1,042,438
+246% +$125M
PFE icon
5
Pfizer
PFE
$142B
$166M 4.66%
5,564,481
+5,232,819
+1,578% +$168M
AGN
6
DELISTED
Allergan plc
AGN
$165M 4.65%
+608,789
New +$187M
BMY icon
7
Bristol-Myers Squibb
BMY
$124B
$123M 3.46%
2,075,777
-28,191
-1% -$1.79M
EW icon
8
Edwards Lifesciences
EW
$48.9B
$112M 3.15%
4,724,580
-638,358
-12% -$15.4M
GILD icon
9
Gilead Sciences
GILD
$162B
$111M 3.11%
+1,125,974
New +$125M
META icon
10
Meta Platforms (Facebook)
META
$1.63T
$98.2M 2.76%
1,092,146
+79,514
+8% +$7.3M
PANW icon
11
Palo Alto Networks
PANW
$279B
$92.9M 2.61%
3,239,106
+863,106
+36% +$25.5M
LLY icon
12
Eli Lilly
LLY
$1.05T
$92.6M 2.6%
+1,106,139
New +$93.4M
TEVA icon
13
Teva Pharmaceuticals
TEVA
$36.5B
$86.9M 2.44%
1,538,865
+329,901
+27% +$21.4M
VMC icon
14
Vulcan Materials
VMC
$36.4B
$82.9M 2.33%
929,900
-114,854
-11% -$10.7M
AER icon
15
AerCap
AER
$23.4B
$80.1M 2.25%
2,093,991
-1,047,764
-33% -$46.3M
HRTX icon
16
Heron Therapeutics
HRTX
$90.3M
$72.3M 2.03%
2,962,656
+1,151,490
+64% +$38.4M
AET
17
DELISTED
Aetna Inc
AET
$70.3M 1.98%
642,915
-137,015
-18% -$15.8M
NOW icon
18
ServiceNow
NOW
$105B
$69.2M 1.95%
4,984,360
+1,279,340
+35% +$19.1M
BRCM
19
DELISTED
BROADCOM CORP CL-A
BRCM
$65.4M 1.84%
1,271,730
-1,466,693
-54% -$75.5M
UHS icon
20
Universal Health Services
UHS
$9.08B
$64.6M 1.82%
517,243
+9,802
+2% +$1.36M
HD icon
21
Home Depot
HD
$331B
$60.8M 1.71%
+526,343
New +$60.9M
MIC
22
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
$59.6M 1.68%
798,443
-309,043
-28% -$24.7M
BKNG icon
23
Booking.com
BKNG
$139B
$56.7M 1.6%
+1,146,950
New +$57M
HOLX
24
DELISTED
Hologic
HOLX
$54.9M 1.54%
1,403,438
-520,324
-27% -$20.6M
MDCO
25
DELISTED
Medicines Co
MDCO
$49M 1.38%
1,289,652
-12,864
-1% -$452K
1
2 3 4 5

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
CPRC
Consolidated Portfolio Review Corp Woodbury, New York $1.1B AUM 8.96% 1-Year Est. Return
AWP
Abacus Wealth Partners Santa Monica, California $1.1B AUM 14.74% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return

PFM Health Sciences's Q3 2015 Portfolio in Review

As of Q3 2015, PFM Health Sciences held 114 positions worth $3.55B, down 10% from $3.95B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

PFM Health Sciences deployed $563M of net new capital in Q3 2015, opening 26 new positions and adding to 23 existing holdings. Its largest new stake was Allergan plc: 608,789 shares worth $165M.

By sector, the portfolio is most concentrated in Healthcare at 59% of assets, up from 48% a quarter earlier, followed by Communication Services and Financials.

On the sell side, the largest reduction was BROADCOM CORP CL-A, an estimated $75.5M trimmed.

  • PFM Health Sciences's largest Q3 2015 buy was Allergan plc: 608,789 shares worth $165M.
  • PFM Health Sciences added most to Pfizer in Q3 2015, an estimated $168M increase.
  • PFM Health Sciences's biggest Q3 2015 reduction was BROADCOM CORP CL-A, cutting an estimated $75.5M.
  • PFM Health Sciences fully exited Elevance Health in Q3 2015, selling an estimated $84.3M.
  • PFM Health Sciences's ten largest holdings make up 43% of its $3.55B portfolio in Q3 2015.
  • PFM Health Sciences opened 26 new positions and closed 40 in Q3 2015.
  • PFM Health Sciences's portfolio value fell 10% quarter-over-quarter to $3.55B.

Based on PFM Health Sciences's 13F filing for Q3 2015, filed 16 Nov 2015.